273 results on '"Schaid, D J"'
Search Results
2. Case-Control Studies of Genetic Markers : Power and Sample Size Approximations for Armitage’s Test for Trend
3. Genetic diversity and function in the human cytosolic sulfotransferases
4. Progression of familial and non-familial dilated cardiomyopathy: long term follow up
5. No fumarate hydratase (FH) mutations in hereditary prostate cancer
6. Identification of Putative Nonfunctional Steroid Receptors in Breast and Endometrial Cancer
7. Exclusion of a primary gene defect at the HLA locus in familial idiopathic dilated cardiomyopathy
8. Germline variation at 8q24 and prostate cancer risk in men of European ancestry
9. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants
10. Progress Report on a Phase II Trial of 5-Fluorouracil Plus Citrovorum Factor in Women with Metastatic Breast Cancer
11. PALB2, CHEK2 and ATM rare variants and cancer risk:data from COGS
12. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
13. Evaluation of Candidate Genes in Case-Control Studies: A Statistical Method to Account for Related Subjects
14. Identification of candidate genes for prostate cancer-risk SNPs utilizing a normal prostate tissue eQTL data set
15. Kernel methods for large-scale genomic data analysis
16. Genes regulating estradiol and estrone-conjugate levels in postmenopausal women with resected early-stage breast cancer detected by a genome-wide association study (GWAS).
17. Comparison of statistics for candidate-gene association studies using cases and parents
18. Family-based association analysis of 42 hereditary prostate cancer families identifies the Apolipoprotein L3 region on chromosome 22q12 as a risk locus
19. Dense genome-wide SNP linkage scan in 301 hereditary prostate cancer families identifies multiple regions with suggestive evidence for linkage
20. Overview of Statistical Genetic Concepts for Pharmacogenomic Studies
21. Genetic diversity and function in the human cytosolic sulfotransferases
22. The complex genetic epidemiology of prostate cancer
23. The gene for HMSN2C maps to 12q23-24: A region of neuromuscular disorders
24. Efficacy of Bilateral Prophylactic Mastectomy in BRCA1 and BRCA2 Gene Mutation Carriers
25. Attention-Deficit/Hyperactivity Disorder(ADHD) Occurrence Among Reading Disabled (RD) and Non-RD Children in a Population-Based Birth Cohort
26. Prevalence and Clinical Significance of Hfe Gene Mutations in Patients With Iron Overload
27. THE AUTHORS REPLY
28. Discovery of Cancer Susceptibility Genes: Study Designs, Analytic Approaches, and Trends in Technology
29. Potential Misinterpretation of the Case-Only Study to Assess Gene-Environment Interaction
30. Gender and Incidence of Reading Disorder in a Birth Cohort, 1976-1982,
31. Microsatellite Instability and 8p Allelic Imbalance in Stage B2 and C Colorectal Cancers
32. Blased Tests of Association: Comparisons of Allele Frequencies when Departing from Hardy-Weinberg Proportions
33. Re: Probability of Carrying a Mutation of Breast--Ovarian Cancer Gene BRCA1 Based on Family History
34. Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis
35. Anticipation in familial Parkinson's disease: A reanalysis of 13 United Kingdom kindreds
36. Etoposide-Cisplatin and Thoracic Radiation Therapy Salvage of Incomplete Responders to a Noncisplatin Induction Regimen for Limited and Extensive Small-Cell Carcinoma of the Lung
37. Novel pattern of P53 mutation in breast cancers from Austrian women.
38. Familial medullary thyroid cancer and prominent corneal nerves: clinical and genetic analysis.
39. Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types
40. On the inheritance of intracranial aneurysms.
41. A Phase II Study of 5,6-Dihydro-5-Azacytidine Hydrochloride in Disseminated Malignant Melanoma
42. Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.
43. Body-composition changes in patients who gain weight while receiving megestrol acetate.
44. Phase II Trial of Recombinant Tumor Necrosis Factor in Disseminated Malignant Melanoma
45. Levamisole Potentiation of Fluorouracil Antiproliferative Activity Mimicked by Orthovanadate, an Inhibitor of Tyrosine Phosphatase
46. Exclusion of calcitonin/alpha-CGRP gene defect in a family with autosomal dominant supravalvular aortic stenosis.
47. A randomized prospective assessment of recombinant leukocyte A human interferon with or without aspirin in advanced renal adenocarcinoma.
48. Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas.
49. Phase II Trial of Recombinant Leukocyte A Interferon (IFN-α2A) Plus l,3-Bis(2-Chloroethyl)-1-Nitrosourea (BCNU) and the Combination Cimetidine with BCNU in Patients with Disseminated Malignant Melanoma
50. 5-Fluorouracil Plus Leucovorin in Women with Metastatic Breast Cancer A Phase II Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.